Français
514.861.1188
info@favintl.org
 
 
• Welcome to FAV

The Foundation on Antivirals “FAV” is a not-for profit international organization affiliated with theInternational Consortium on Anti-Virals "ICAV"

Our primary objective is to accelerate the discovery, development and delivery of new antiviral therapies.  In so doing, the potential impact of a major pandemic infection, circling the globe within hours and killing millions, should be greatly reduced.

Our mission is to raise funds to develop and make available, at reasonable cost, new antiviral therapies that can save millions of lives worldwide.

 
• Infectious Diseases

• Infectious diseases threaten us all

Worldwide, infectious diseases account for over one-fifth of all deaths, killing - some 17 million people a year....
click here to read more »

• The “10/90 Gap”
Despite these sobering statistics, few drugs are available to treat these diseases - and even fewer reach those in greatest need....
click here to read more »

• Global impact
Pandemics pose an immense threat to global social and economic security....
click here to read more »
 
• Videos/Interviews
Fighting Pandemics

With the world on alert for the next swine flu outbreak, one airline industry veteran wonders if we're ready. BNN talks to Pierre Jeanniot, former CEO, Air Canada, former director general, IATA, and founding chairman, Foundation on Antivirals.
click here to watch »

Interview with

Dr. Michel Chrétien, MD, O.C., O.Q. Scientific Director and Founder of FAV.
click here to watch the interview »

 
did you know that

Infectious diseases are a primary cause of death in the developing countries and a major impediment to their economic and social development.

  • 2.5 million people die each year from AIDS, many of them in sub-Saharan Africa
  • Over 2.5 billion people are at risk of infection with Dengue fever; and 50 million are infected each year
  • Rotavirus, a cause of common diarrhoea, kills an estimated 600,000
    children each year
  • 170 million people are chronically infected with hepatitis C – 3% of the
    world’s population
  • In West Africa alone, there are 500,000 cases of Lassa fever a year
 

The ICAV Solution

ICAV is an institutional innovation that bridges the anti-viral gap...
 

FAV Brochure

An overview of the Foundation –
Who we are
 
 
 
© Copyright - FAV International - All rights managed
Website design : Phil Communications Creative Design Studio